IP Verse

Methods For Detecting Contaminants In Solutions Containing Glucose Polymers - EP2694961

The patent EP2694961 was granted to Roquette Freres on Jan 5, 2022. The application was originally filed on Apr 6, 2012 under application number EP12720540A. The patent is currently recorded with a legal status of "Patent Maintained As Amended".

EP2694961

ROQUETTE FRERES
Application Number
EP12720540A
Filing Date
Apr 6, 2012
Status
Patent Maintained As Amended
Dec 3, 2021
Grant Date
Jan 5, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ALBEON INVEST ZRTOct 2, 2019KOVARIADMISSIBLE

Patent Citations (9) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONEP0207676
DESCRIPTIONEP0667356
DESCRIPTIONUS2007184496
DESCRIPTIONUS2009239819
DESCRIPTIONWO2010125315
INTERNATIONAL-SEARCH-REPORTUS2007184496
INTERNATIONAL-SEARCH-REPORTUS2009239819
OPPOSITIONUS2009239819
OPPOSITIONWO2009115533

Non-Patent Literature (NPL) Citations (16) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- HUANG L.-Y. ET AL., "Use of toll-like receptor assays to detect and identify microbial contaminants in biological products", J. CLIN. MICROBIOL., (200911), vol. 47, no. 11, pages 3427 - 3434, XP002690887
EXAMINATION- IYER J.K. ET AL., "Cutting Edge: Primary innate immune cells respond efficiently to polymeric peptidoglycan, but not to peptidoglycan monomers", J. IMMUNOL., (20110401), vol. 186, no. 7, pages 3841 - 3845, XP055374712
INTERNATIONAL-SEARCH-REPORT- VOWELS B.R. ET AL., "Induction of proinflammatory cytokines by a soluble factor of Propionibacterium acnes: implications for chronic inflammatory acne", INFECT. IMMUN., (199508), vol. 63, no. 8, pages 3158 - 3165, XP002545146 [Y] 23,30 * abstract *-
INTERNATIONAL-SEARCH-REPORT- GLORIEUX G. ET AL., "A novel bio-assay increases the detection yield of microbiological impurity of dialysis fluid, in comparison to the LAL-test", NEPHROL. DIAL. TRANSPLANT., (200902), vol. 24, no. 2, pages 548 - 554, XP002667055 [X] 1-6,13,22 * the whole document * [Y] 23,30 [I] 7-12,14-21,24-29
OPPOSITION- anonymous, "HEK-Blue Tm-hTLR2 Cells", InvivoGen - Technical datasheet, (20101226), URL: http://web.archive.orq/web/20101226121433/https://www.invivogen.com/sites/default/files/invivogen/products/files/hek_blue_htlr2_tds.pdf, XP055646544-
OPPOSITION- DE JONGE et al., "Peptidoglycan Composition of a Highly Methicillin-resistant Staphylococcus aureus Strain", J Biol Chem, (19920605), vol. 267, no. 16, pages 11248 - 11254, XP055646528-
OPPOSITION- BURGER-KENTISCHER A et al., "A new cell -based innate immune receptor assay for the examination of receptor activity, ligand specificity, signalling pathways and the detection of pyrogens", J Immunol Methods, (20100630), vol. 358, no. 1-2, doi:10.1016/j.jim.2010.03.020, pages 93 - 103, XP055012870
OPPOSITION- TRAVASSOS LH et al., "Toll-like receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition", EMBO Rep., (20041000), vol. 5, no. 10, doi:10.1038/sj.embor.7400248, pages 1000 - 1006, XP055123620
OPPOSITION- FILIPE, S et al., "Requirements of peptidoglycan structure that allow detection by the Drosophila Toll pathway", EMBO reports, (20050500), vol. 6, no. 4, doi:10.1038/sj.embor.7400371, pages 327 - 33, XP008111925
OPPOSITION- CHETTY C et al., "Soluble peptidoglycan-polysaccharide fragments of the bacterial cell wall induce acute inflammation", Infect Immun., (19821200), vol. 38, no. 3, pages 1010 - 1019, XP055646526
OPPOSITION- DZIARSKI R et al., "Staphylococcus aureus peptidoglycan is a toll-like receptor 2 activator: a reevaluation", Infect Immun., (20050800), vol. 73, no. 8, doi:10.1128/IAI.73.8.5212-5216.2005, pages 5212 - 5216, XP055123546
OPPOSITION- HUANG LY et al., "Use of toll-like receptor assays to detect and identify microbial contaminants in biological products", J Clin Micobiol, (20091104), vol. 7, no. 11, doi:10.1128/JCM.00373-09, pages 3427 - 3434, XP002690887
OPPOSITION- ERRIDGE C et al., "The induction of colitis and ileitis in mice is associated with marked increases in intestinal concentrations of stimulants of TLRs 2, 4, and 5", PLoS One, (20100200), vol. 5, no. 2, doi:10.1371/journal.pone.0009125, page e9125, XP055050919
OPPOSITION- KUMAR H et al., "Pathogen Recognition by the Innate Immune System", Int Rev Immunol, (20110114), vol. 30, no. 1, pages 16 - 34, XP055646536
OPPOSITION- QI H et al., "Comparison of icodextrin and glucose solutions for long dwell exchange in peritoneal dialysis: a meta-analysis of randomized controlled trials", Perit Dial Int., (20110300), vol. 31, no. 2, pages 179 - 88, XP055646532
OPPOSITION- IYER JK et al., "Cutting Edge: Primary innate immune cells respond efficiently to polymeric peptidoglycan, but not to peptidoglycan monomers", J Immunol, (20110401), vol. 186, no. 7, doi:10.4049/jimmunol.1004058, pages 3841 - 3845, XP055374712

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents